AlTi Global’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$907K Sell
21,244
-11,221
-35% -$609K 0.02% 282
2026
Q1
$2.04M Buy
32,465
+6,729
+26% +$538K 0.04% 156
2025
Q4
$2.45M Buy
25,736
+14,938
+138% +$1.46M 0.05% 142
2025
Q3
$1.05M Sell
10,798
-1,094
-9% -$113K 0.02% 235
2025
Q2
$1.24M Sell
11,892
-3,535
-23% -$358K 0.03% 206
2025
Q1
$1.56M Buy
15,427
+1,600
+12% +$161K 0.04% 163
2024
Q4
$1.36M Sell
13,827
-717
-5% -$63.1K 0.03% 191
2024
Q3
$1.22M Sell
14,544
-1,550
-10% -$122K 0.03% 200
2024
Q2
$1.24M Sell
16,094
-3,922
-20% -$287K 0.03% 191
2024
Q1
$1.37M Sell
20,016
-3,588
-15% -$231K 0.04% 178
2023
Q4
$1.36M Buy
+23,604
New +$1.26M 0.04% 161

Other funds holding BSX

AlTi Global's BSX Position: Q2 2026 in Review

AlTi Global reduced its Boston Scientific (BSX) stake by 35% in Q2 2026, selling an estimated $609K and leaving 21,244 shares worth $907K. The position accounts for 0.02% of the portfolio, ranked #282.

AlTi Global first reported a position in BSX in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.45M in Q4 2025. 770 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • AlTi Global held 21,244 shares of Boston Scientific worth $907K as of Q2 2026.
  • AlTi Global sold 11,221 Boston Scientific shares in Q2 2026, an estimated $609K.
  • Boston Scientific made up 0.02% of AlTi Global's portfolio in Q2 2026, its #282 holding.
  • AlTi Global first reported a position in Boston Scientific in Q4 2023 and has held it in 11 quarters since.
  • AlTi Global's Boston Scientific position peaked at $2.45M in Q4 2025.
  • 770 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on AlTi Global's 13F filing for Q2 2026, filed 5 Aug 2026.